pharmaphorum Podcast Podcast Por pharmaphorum arte de portada

pharmaphorum Podcast

pharmaphorum Podcast

De: pharmaphorum
Escúchala gratis

pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.© 2022 Pharmaphorum Ciencia Ciencias Biológicas Economía Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Creating what nature has not from AI and computational molecular biophysics with Kashif Sadiq
    Mar 31 2026

    In a new episode of the pharmaphorum podcast, recorded at BIO-Europe Spring in Lisbon, Portugal, web editor Nicole Raleigh spoke with Kashif Sadiq, founder and CEO of DenovAI Biotech, a company that believes humanity is on the cusp of a protein design revolution that stands to transform both human health and the world around us.

    Sadiq discusses the company's springboard from AION Labs - with a first-of-its-kind alliance of AstraZeneca, Merck, Pfizer, Teva, the Israel Biotech Fund, Amiti Ventures, and Amazon Web Services, powered by BioMed X with the support of the Israeli Government.

    He also explores harnessing the power of artificial intelligence and computational molecular biophysics, developing foundational technology platforms that can design proteins de novo, and describes the trends and insights from the conference itself this year.

    Más Menos
    14 m
  • On collaboration, computational chemistry, and cutting-edge AI – with Olga Nissan
    Mar 25 2026

    At BIO-Europe Spring 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Dr Olga Nissan, vice president of business development at Evogene, a computational chemistry company, specialising in the generative design of small molecules for the pharmaceutical and agricultural industries.

    Nissan discusses recent developments at Evogene, including its extended collaboration with Google Cloud to develop and integrate AI agents into Evogene’s ChemPass AI platform, as well as its collaboration with Queensland University of Technology in the non-small cell lung cancer (NSCLC) space. She also speaks to where industry is at in its integration of cutting-edge AI into scientific research.

    Más Menos
    11 m
  • Making AI work where it matters, with Rob DiCicco
    Mar 17 2026

    In a new pharmaphorum podcast, web editor Nicole Raleigh was joined by Rob DiCicco, vice president of portfolio management at Transcelerate Biopharma Inc, for a conversation on the barriers and the breakthroughs in making AI work in drug development and clinical trials.

    DiCicco discusses why AI adoption in clinical trials is so different from preclinical research and development, as well as how synthetic control arms and in silico modelling reshape trial design, and he touches upon the need for making AI solutions meet not just regulatory and scientific standards, but ethical standards, also.

    You can listen to episode 250 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

    Más Menos
    19 m
Todavía no hay opiniones